Latest News

EssilorLuxottica Société anonyme (ENXTPA:EL) has put fresh numbers on the table for FY 2025, with second half revenue of €14.5b, basic EPS of €2.01 and net income of €928m, while trailing twelve month revenue sits at €28.5b with EPS of €5.04 and net income of €2.3b. The company has seen revenue move from €13.2b and EPS of €2.18 in 2024 H2 to €14.5b and EPS of €2.01 in 2025 H2, alongside forecast annual revenue growth of 8.1% and EPS growth of 13.3%. Investors are likely to focus on how these...

The Star Entertainment Group Limited ( ASX:SGR ) shares have retraced a considerable 26% in the last month, reversing a...

When close to half the companies in Australia have price-to-earnings ratios (or "P/E's") above 22x, you may consider...

WAM Strategic Value Limited ( ASX:WAR ) will pay a dividend of A$0.0325 on the 29th of May. The dividend yield will be...

Sterling Infrastructure, Inc. ( NASDAQ:STRL ) shareholders have had their patience rewarded with a 34% share price jump...

Mibanco, the microfinance arm of Credicorp (NYSE:BAP), is partnering with Temenos to modernize its core banking platform using software as a service. The collaboration focuses on faster product launches, improved customer experience, and broader financial inclusion for small businesses in Peru. For Credicorp, which has a strong presence in microfinance through Mibanco, this tech upgrade relates directly to how banking services are delivered to small and midsize enterprises in Peru. The move...

Civmec (ASX:CVL) has laid out a fresh set of H1 2026 numbers, with the latest half showing total revenue of A$307.7 million and basic EPS of A$0.03 alongside net income of A$16.0 million. Over recent halves the company has seen revenue move from A$541.1 million and EPS of A$0.06 in H2 2024 to A$502.9 million and EPS of A$0.05 in H1 2025. This sets the backdrop for today’s update and the current share price of A$1.56, and investors are now weighing those headline figures against slightly...

Confluent (CFLT) just wrapped up FY 2025 with Q4 revenue of US$314.8 million and a basic EPS loss of US$0.23, while trailing twelve month revenue sat at about US$1.17 billion against a full year basic EPS loss of US$0.86. Over recent quarters, the company has seen revenue move from US$261.2 million in Q4 2024 to US$314.8 million in Q4 2025, with quarterly basic EPS losses ranging between US$0.19 and US$0.27. The latest print keeps the spotlight firmly on how quickly revenue growth can offset...

If you are wondering whether PennyMac Mortgage Investment Trust is offering good value at its recent share price, you are not alone. This article is designed to help you make sense of that question. The stock most recently closed at US$12.49, with returns of 2.0% over the past week, a 5.2% decline over the past month, a 1.3% decline year to date, and a 3.4% return over the last year, alongside cumulative returns of 26.2% over three years and 22.1% over five years. Recent coverage has focused...

Cochlear (ASX:COH) has reported its H1 2026 results with trailing twelve month revenue of A$2.3b and basic EPS of A$5.28, giving investors a clear read on both top line scale and earnings power. The company has seen half year revenue move from A$1,137.1 million in H2 2024 to A$1,171.8 million in H1 2025 and A$1,171.3 million in H2 2025, while basic EPS shifted from A$2.53 to A$3.13 and then A$2.81 over the same periods. This sets the backdrop for a margin story that investors will parse...

What is moving Amphastar Pharmaceuticals now? Amphastar Pharmaceuticals (AMPH) has drawn investor attention after its recent share performance, with the stock around $27.55 and short term returns mixed between the past week, month and past 3 months. See our latest analysis for Amphastar Pharmaceuticals. At around $27.55, Amphastar Pharmaceuticals has given investors a mixed ride, with recent share price returns over the past week and month soft, while the 90 day share price return of 5.72%...

Organigram Global (TSX:OGI) is back in focus after reporting first quarter 2026 results that shifted from a net loss to net income, with higher sales and revenue, as well as positive earnings per share. See our latest analysis for Organigram Global. Despite the swing back to net income, Organigram Global’s share price has had a tough run, with a 30 day share price return of a 26.6% decline and a 1 year total shareholder return of a 9.4% decline. This may suggest that recent enthusiasm around...

In early February 2026, PotlatchDeltic Corporation was removed from the NASDAQ Composite Index, while multiple long-running ESOP-related shelf registrations for common stock were formally closed. This combination highlights how a technical index change, rather than routine employee stock plan administration, can have an outsized influence on trading flows and investor attention. Next, we’ll examine how PotlatchDeltic’s removal from the NASDAQ Composite Index could affect its existing...

Nick Scali (ASX:NCK) has released its H1 2026 scorecard, with investors already eyeing how the latest numbers fit into the broader trend in revenue and EPS. The company has seen half year revenue move from A$241.6 million in H2 2024 to A$251.1 million in H1 2025 and then A$244.2 million in H2 2025, while basic EPS shifted from A$0.457 to A$0.351 and then A$0.324 over the same periods. This gives investors a clear view of how recent trading has flowed through to the bottom line. With net...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Travel + Leisure fair value estimate is US$100 Current share...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

As the Canadian market navigates a landscape where technology stocks are experiencing valuation adjustments due to AI-driven disruptions and increased capital spending, investors are re-evaluating their strategies. Amidst this backdrop, penny stocks—often associated with smaller or newer companies—offer intriguing opportunities for those looking beyond the established giants. While the term might seem outdated, these stocks continue to provide potential growth at lower price points when...

To the annoyance of some shareholders, EROAD Limited ( NZSE:ERD ) shares are down a considerable 28% in the last month...

As February begins, the United States stock markets have shown strong performance, with major indices like the Dow Jones Industrial Average and S&P 500 experiencing significant gains. This positive momentum in the market presents an opportunity to explore stocks that may be undervalued, potentially trading below their estimated intrinsic value. Identifying such stocks requires a keen understanding of current market conditions and economic indicators to evaluate their true potential amidst...

As February begins, U.S. stock markets have shown a strong start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting positive investor sentiment amid economic developments such as a new trade deal with India. In this thriving market environment, companies that exhibit high insider ownership often signal confidence from those who know the business best, making them potentially attractive options for growth-focused investors seeking...

As February 2026 begins, major U.S. stock indexes have shown robust performance, with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing record highs. This market momentum sets a promising backdrop for exploring investment opportunities in various sectors. Despite its somewhat outdated terminology, the concept of penny stocks remains significant as these smaller or newer companies can offer a blend of affordability and growth potential when backed by strong financials...

As February 2026 begins, the U.S. stock market is experiencing a surge, with major indices like the Dow Jones and S&P 500 showing strong performances despite recent economic uncertainties such as delayed jobs data due to a government shutdown and shifting trade dynamics. In this vibrant yet complex environment, discovering lesser-known stocks that have potential for growth can be an intriguing prospect for investors looking to diversify their portfolios amidst evolving market conditions.

Cohu (NasdaqGS:COHU) reported strong Q4 revenue growth alongside a larger than expected quarterly loss. Management pointed to increasing demand tied to high-bandwidth memory and AI related markets. The company highlighted design wins and solid order activity in automotive, computing, and advanced packaging. Cohu, which supplies test and handling equipment for semiconductor manufacturing, is focusing on areas where chip complexity and performance requirements are rising. High-bandwidth...

Similarweb (SMWB) has drawn fresh attention after launching AI Studio, an enterprise AI intelligence platform that lets clients query its extensive digital data through conversational research, deep reports, and auto generated dashboards for business decision support. See our latest analysis for Similarweb. The AI Studio launch and Bloomberg Terminal integration arrive during a weak patch for the stock, with Similarweb’s 30 day share price return of 39.16% and year to date share price return...